MENU
+Compare
PLSE
Stock ticker: NASDAQ
AS OF
Sep 17, 04:59 PM (EDT)
Price
$16.30
Change
-$0.34 (-2.04%)
Capitalization
1.12B

PLSE Pulse Biosciences Forecast, Technical & Fundamental Analysis

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue... Show more

PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PLSE with price predictions
Sep 16, 2025

PLSE's Indicator enters downward trend

The Aroon Indicator for PLSE entered a downward trend on September 16, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 215 similar instances where the Aroon Indicator formed such a pattern. In of the 215 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PLSE moved out of overbought territory on August 15, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The 10-day moving average for PLSE crossed bearishly below the 50-day moving average on September 09, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PLSE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PLSE broke above its upper Bollinger Band on September 16, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where PLSE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 15, 2025. You may want to consider a long position or call options on PLSE as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PLSE just turned positive on September 16, 2025. Looking at past instances where PLSE's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

PLSE moved above its 50-day moving average on September 15, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PLSE advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PLSE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.482) is normal, around the industry mean (11.003). P/E Ratio (0.000) is within average values for comparable stocks, (57.978). PLSE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.758). PLSE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.000) is also within normal values, averaging (16.987).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PLSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
PLSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PLSE is expected to report earnings to fall 12.90% to -27 cents per share on November 17

Pulse Biosciences PLSE Stock Earnings Reports
Q3'25
Est.
$-0.27
Q4'24
Missed
by $0.07
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.10
The last earnings report on March 27 showed earnings per share of -31 cents, missing the estimate of -23 cents. With 226.54K shares outstanding, the current market capitalization sits at 1.12B.
A.I. Advisor
published General Information

General Information

a development stage company, which manufactures surgical and medical instruments

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3957 Point Eden Way
Phone
+1 510 906-4600
Employees
56
Web
https://www.pulsebiosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSGCX20.44N/A
N/A
Columbia Cornerstone Equity C
FRUSX24.63N/A
N/A
Franklin Utilities C
GLBIX10.06N/A
N/A
Leuthold Global Institutional
HNMDX13.74N/A
N/A
Heartland Mid Cap Value Institutional
BHCHX18.45-0.07
-0.39%
Baron Health Care Instl

PLSE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PLSE has been loosely correlated with CERS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PLSE jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+5.72%
CERS - PLSE
38%
Loosely correlated
+5.00%
CLPT - PLSE
32%
Poorly correlated
+1.72%
ARAY - PLSE
32%
Poorly correlated
N/A
TMCI - PLSE
32%
Poorly correlated
-2.08%
QDEL - PLSE
32%
Poorly correlated
+2.11%
More

Groups containing PLSE

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLSE
1D Price
Change %
PLSE100%
+5.72%
Pharmaceuticals: Other
industry (103 stocks)
18%
Poorly correlated
-0.35%
Pharmaceuticals
industry (385 stocks)
16%
Poorly correlated
-0.07%